PHIAKoninklijke Philips N.V.
+1.9% today · +7.8% over a year
3/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 46% of the instruments we score
Priced lower than most peers. Dividend yield 3.51%.
Koninklijke Philips N.V. (PHIA) belongs to the Health care sector and is listed on Euronext Amsterdam; country: Netherlands. Its market value is about €23.3B. Over the past 12 months the price changed by +7.8%, with an annualised volatility of 27% and a largest fall of 20%.
Smart Score
How it is scored →The Smart Score (1–10) describes how this instrument compares with its peers on published, rules-based measures of value, quality, trend, stability and dividend safety. It is not a forecast and not personal advice.
Compared with: Health care companies in Europe (n = 45)
Current rating first published: · last recomputed · rating log
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Gross profit growth / assets (5 y)weighs on the score · better than 17% of peers
- Volatility (1 y)supports the score · better than 81% of peers
- Revenue growth (5 y, a year)weighs on the score · better than 12% of peers
Red flags and notes
- Caution. Dividend Safety below 40 points. More in the glossary → Dividend Safety below 40 points.
- Caution. Dividends grew 5+ points a year faster than earnings over five years and the payout is above 75 %. More in the glossary → Dividends grew 5+ points a year faster than earnings over five years and the payout is above 75 %.
Our rules see a meaningful risk that this dividend is cut.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/E
- 26.1
- P/B
- 2.1
- P/S
- 1.3
- EV/EBIT
- 20.1
- Market cap (EUR)
- €23.3B
Profitability and debt
- Return on equity
- 7.8%
- Return on invested capital
- 6.5%
- Gross margin
- 45.2%
- Net debt / EBITDA
- 2.08
Dividends
- Dividend yield
- 3.51%
- Payout ratio
- 91%
- 5-year dividend growth (per year)
- 1.6%
- Years of dividend growth
- 0
Returns and risk
- 1 day
- +1.9%
- 1 month
- +10.3%
- 1 year
- +7.8%
- Volatility, 1 yr
- 26.5%
- Max drawdown, 1 yr
- −20.5%
- Beta
- 1.06
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| ROIVRoivant Sciences Ltd. | 1/10 | 0.0% | 101.6% |
|---|---|---|---|
| STESTERIS | 9/10 | 1.1% | −4.3% |
| BNTXBioNTech SE | —/10 | 0.0% | −16.2% |
| ALCAlcon AG | 6/10 | 0.5% | −2.6% |
| ALCAlcon | 4/10 | 0.4% | −6.2% |
| ICLRICON plc | 3/10 | 0.0% | 20.5% |
| ASNDAscendis Pharma A/S | 4/10 | 0.0% | 21.2% |
| TEVATeva Pharmaceutical Industries Limited | 6/10 | 0.0% | 102.1% |
News and filings
No recent news or filings in our sources.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 1 entry
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | 3/10 | 4 · 1 | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.